Veterinary Medicines

FYPERIX COMBO 50 MG/60 MG SPOT-ON SOLUTION FOR CATS AND FERRETS

Authorised
  • Fipronil
  • Methoprene
Download as PDF

Product identification

Medicine name:
FYPERIX COMBO 50 MG/60 MG SPOT-ON SOLUTION FOR CATS AND FERRETS
Amflee combo 50 mg/60 mg spot-on oplossing voor katten en fretten
Active substance:
  • Fipronil
  • Methoprene
Target species:
  • Cat
  • Ferret
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Fipronil
    50.00
    milligram(s)
    /
    1.00
    Pipette
  • Methoprene
    60.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX65
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • White polypropylene unit-dose pipette with polyethylene or polyoxymethylene closure with spike packaged into laminated triplex bag composed of polyester, aluminium and polyethylene. Cardboard box containing 1 pipette.
  • White polypropylene unit-dose pipette with polyethylene or polyoxymethylene closure with spike packaged into laminated triplex bag composed of polyester, aluminium and polyethylene. Cardboard box containing 30 pipettes
  • White polypropylene unit-dose pipette with polyethylene or polyoxymethylene closure with spike packaged into laminated triplex bag composed of polyester, aluminium and polyethylene. Cardboard box containing 10 pipettes
  • White polypropylene unit-dose pipette with polyethylene or polyoxymethylene closure with spike packaged into laminated triplex bag composed of polyester, aluminium and polyethylene. Cardboard box containing 6 pipettes
  • White polypropylene unit-dose pipette with polyethylene or polyoxymethylene closure with spike packaged into laminated triplex bag composed of polyester, aluminium and polyethylene. Cardboard box containing 3 pipettes

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • TAD Pharma GmbH
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 117509
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0333/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Estonia
  • Germany
  • Greece
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 10/06/2025
Download